E-ISSN: 2147-1959
Short Latency Radiation Induced Osteosarcoma Detected on <sup>18</sup>F-FDG PET/CT Scan in Solitary Plasmacytoma
PDF
Cite
Share
Request
Interesting Image
VOLUME: 31 ISSUE: 1
P: 66-68
February 2022

Short Latency Radiation Induced Osteosarcoma Detected on 18F-FDG PET/CT Scan in Solitary Plasmacytoma

Mol Imaging Radionucl Ther 2022;31(1):66-68
DOI: 10.4274/mirt.galenos.2020.26566
Sana Munir Gill 1
Aamna Hassan 1
Namra Asghar 1
Usman Ahmad 2
Umm e Kalsoom Awan 2
Imran Khalid Niazi 3
1. Shaukat Khanum Memorial Cancer Hospital and Research Centre, Department of Nuclear Medicine, Lahore, Pakistan
2. Shaukat Khanum Memorial Cancer Hospital and Research Centre, Department of Medical Oncology, Lahore, Pakistan
3. Shaukat Khanum Memorial Cancer Hospital and Research Centre, Department of Radiology, Lahore, Pakistan
No information available.
No information available
Received Date: 08.06.2020
Accepted Date: 24.11.2020
Publish Date: 02.02.2022
PDF
Cite
Share
Request

ABSTRACT

18Fluorine-fluorodeoxyglucose (18F-FDG) positron emission tomography/computed tomography (PET/CT) plays a pivotal role in the staging, restaging, and surveillance of various bone tumors, including plasmacytomas and osteosarcomas. Solitary plasmacytomas most frequently occur in the bones and are primarily treated with either surgery or radiotherapy. Radiation-induced osteosarcomas (RIOS) usually develop after a median interval of 11 years between radiation and sarcoma presentation. However, these can rarely present with a short latent period of 4 years or even lesser. In such cases, whole-body imaging plays a vital role in the early detection and management of RIOS. Herein, we present the case of a 29-year-old female patient with solitary plasmacytoma undergoing a follow-up whole-body 18F-FDG PET/CT, which revealed metastatic RIOS after a short latent period.

References

1
Ali SA, Hamed MAE. The diagnostic efficacy of whole body 18F-FDG PET CT in detection of unexpected second primary malignancy in cancer patients. EJRNM 2017;48:671-676.
2
Zhang X, Guan Z. PET/CT in the diagnosis and prognosis of osteosarcoma. Front Biosci (Landmark Ed) 2018;23:2157-2165.
3
Nanni C, Rubello D, Zamagni E, Castellucci P, Ambrosini V, Montini G, Cavo M, Lodi F, Pettinato C, Grassetto G, Franchi R, Gross MD, Fanti S. 18F-FDG PET/CT in myeloma with presumed solitary plasmocytoma of bone. In Vivo 2008;22:513-517.
4
Rustemeyer P, Micke O, Blasius S, Peters PE. Radiation-induced malignant mesenchymoma of the chest wall following treatment for breast cancer. Br J Radiol 1997;70:424-426.
5
Tsuda Y, Ogura K, Shinoda Y, Kobayashi H, Tanaka S, Kawai A. The outcomes and prognostic factors in patients with osteosarcoma according to age: a Japanese nationwide study with focusing on the age differences. BMC Cancer 2018;18:614.
6
Mavrogenis AF, Pala E, Guerra G, Ruggieri P. Post-radiation sarcomas. Clinical outcome of 52 Patients. J Surg Oncol 2012;105:570-576.